Cargando…
A new tetrakis-substituted pyrazine carboxylic acid, 3,3′,3′′,3′′′-{[pyrazine-2,3,5,6-tetrayltetrakis(methylene)]tetrakis(sulfanediyl)}tetrapropionic acid: crystal structures of two triclinic polymorphs and of two potassium–organic frameworks
Two polymorphs of the title tetrakis-substituted pyrazine carboxylic acid, 3,3′,3′′,3′′′-{[pyrazine-2,3,5,6-tetrayltetrakis(methylene))tetrakis(sulfanediyl]}tetrapropionic acid, C(20)H(28)N(2)O(8)S(4), (H(4)L1), have been obtained, H(4)L1_A and H(4)L1_B. Each structure crystallized with h...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Union of Crystallography
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8100264/ https://www.ncbi.nlm.nih.gov/pubmed/34026250 http://dx.doi.org/10.1107/S2056989021003479 |
_version_ | 1783688747752095744 |
---|---|
author | Pacifico, Jessica Stoeckli-Evans, Helen |
author_facet | Pacifico, Jessica Stoeckli-Evans, Helen |
author_sort | Pacifico, Jessica |
collection | PubMed |
description | Two polymorphs of the title tetrakis-substituted pyrazine carboxylic acid, 3,3′,3′′,3′′′-{[pyrazine-2,3,5,6-tetrayltetrakis(methylene))tetrakis(sulfanediyl]}tetrapropionic acid, C(20)H(28)N(2)O(8)S(4), (H(4)L1), have been obtained, H(4)L1_A and H(4)L1_B. Each structure crystallized with half a molecule in the asymmetric unit of a triclinic P [Image: see text] unit cell. The whole molecules are generated by inversion symmetry, with the pyrazine rings being located about inversion centers. The crystals of H(4)L1_B were of poor quality, but the X-ray diffraction analysis does show the change in conformation of the –CH(2)—S—CH(2)—CH(2)– side chains compared to those in polymorph H(4)L1_A. In the crystal of H(4)L1_A, molecules are linked by two pairs of O—H⋯O hydrogen bonds, enclosing R (2) (2)(8) ring motifs forming layers parallel to plane (100), which are linked by C—H⋯O hydrogen bonds to form a supramolecular framework. In the crystal of H(4)L1_B, molecules are also linked by two pairs of O—H⋯O hydrogen bonds enclosing R (2) (2)(8) ring motifs, however here, chains are formed propagating in the [001] direction and stacking up the a-axis. Reaction of H(4)L1 with Hg(NO(3))(2) in the presence of a potassium acetate buffer did not produce the expected binuclear complex, instead crystals of a potassium–organic framework were obtained, poly[(μ-3-{[(3,5,6-tris{[(2-carboxyethyl)sulfanyl]methyl}pyrazin-2-yl)methyl]sulfanyl}propanoato)potassium], [K(C(20)H(27)N(2)O(8)S(4))](n) (KH(3)L1). The organic mono-anion possesses inversion symmetry with the pyrazine ring being located about an inversion center. A carboxy H atom is disordered by symmetry and the charge is compensated for by a potassium ion. A similar reaction with Zn(NO(3))(2) resulted in the formation of crystals of a dipotassium-organic framework, poly[(μ-3,3′-{[(3,6-bis{[(2-carboxyethyl)sulfanyl]methyl}pyrazine-2,5-diyl)bis(methylene)]bis(sulfanediyl)}dipropionato)dipotassium], [K(2)(C(20)H(26)N(2)O(8)S(4))](n) (K(2)H(2)L1). Here, the organic di-anion possesses inversion symmetry with the pyrazine ring being located about an inversion center. Two symmetry-related acid groups are deprotonated and the charges are compensated for by two potassium ions. |
format | Online Article Text |
id | pubmed-8100264 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | International Union of Crystallography |
record_format | MEDLINE/PubMed |
spelling | pubmed-81002642021-05-21 A new tetrakis-substituted pyrazine carboxylic acid, 3,3′,3′′,3′′′-{[pyrazine-2,3,5,6-tetrayltetrakis(methylene)]tetrakis(sulfanediyl)}tetrapropionic acid: crystal structures of two triclinic polymorphs and of two potassium–organic frameworks Pacifico, Jessica Stoeckli-Evans, Helen Acta Crystallogr E Crystallogr Commun Research Communications Two polymorphs of the title tetrakis-substituted pyrazine carboxylic acid, 3,3′,3′′,3′′′-{[pyrazine-2,3,5,6-tetrayltetrakis(methylene))tetrakis(sulfanediyl]}tetrapropionic acid, C(20)H(28)N(2)O(8)S(4), (H(4)L1), have been obtained, H(4)L1_A and H(4)L1_B. Each structure crystallized with half a molecule in the asymmetric unit of a triclinic P [Image: see text] unit cell. The whole molecules are generated by inversion symmetry, with the pyrazine rings being located about inversion centers. The crystals of H(4)L1_B were of poor quality, but the X-ray diffraction analysis does show the change in conformation of the –CH(2)—S—CH(2)—CH(2)– side chains compared to those in polymorph H(4)L1_A. In the crystal of H(4)L1_A, molecules are linked by two pairs of O—H⋯O hydrogen bonds, enclosing R (2) (2)(8) ring motifs forming layers parallel to plane (100), which are linked by C—H⋯O hydrogen bonds to form a supramolecular framework. In the crystal of H(4)L1_B, molecules are also linked by two pairs of O—H⋯O hydrogen bonds enclosing R (2) (2)(8) ring motifs, however here, chains are formed propagating in the [001] direction and stacking up the a-axis. Reaction of H(4)L1 with Hg(NO(3))(2) in the presence of a potassium acetate buffer did not produce the expected binuclear complex, instead crystals of a potassium–organic framework were obtained, poly[(μ-3-{[(3,5,6-tris{[(2-carboxyethyl)sulfanyl]methyl}pyrazin-2-yl)methyl]sulfanyl}propanoato)potassium], [K(C(20)H(27)N(2)O(8)S(4))](n) (KH(3)L1). The organic mono-anion possesses inversion symmetry with the pyrazine ring being located about an inversion center. A carboxy H atom is disordered by symmetry and the charge is compensated for by a potassium ion. A similar reaction with Zn(NO(3))(2) resulted in the formation of crystals of a dipotassium-organic framework, poly[(μ-3,3′-{[(3,6-bis{[(2-carboxyethyl)sulfanyl]methyl}pyrazine-2,5-diyl)bis(methylene)]bis(sulfanediyl)}dipropionato)dipotassium], [K(2)(C(20)H(26)N(2)O(8)S(4))](n) (K(2)H(2)L1). Here, the organic di-anion possesses inversion symmetry with the pyrazine ring being located about an inversion center. Two symmetry-related acid groups are deprotonated and the charges are compensated for by two potassium ions. International Union of Crystallography 2021-04-09 /pmc/articles/PMC8100264/ /pubmed/34026250 http://dx.doi.org/10.1107/S2056989021003479 Text en © Pacifico and Stoeckli-Evans 2021 https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited. |
spellingShingle | Research Communications Pacifico, Jessica Stoeckli-Evans, Helen A new tetrakis-substituted pyrazine carboxylic acid, 3,3′,3′′,3′′′-{[pyrazine-2,3,5,6-tetrayltetrakis(methylene)]tetrakis(sulfanediyl)}tetrapropionic acid: crystal structures of two triclinic polymorphs and of two potassium–organic frameworks |
title | A new tetrakis-substituted pyrazine carboxylic acid, 3,3′,3′′,3′′′-{[pyrazine-2,3,5,6-tetrayltetrakis(methylene)]tetrakis(sulfanediyl)}tetrapropionic acid: crystal structures of two triclinic polymorphs and of two potassium–organic frameworks |
title_full | A new tetrakis-substituted pyrazine carboxylic acid, 3,3′,3′′,3′′′-{[pyrazine-2,3,5,6-tetrayltetrakis(methylene)]tetrakis(sulfanediyl)}tetrapropionic acid: crystal structures of two triclinic polymorphs and of two potassium–organic frameworks |
title_fullStr | A new tetrakis-substituted pyrazine carboxylic acid, 3,3′,3′′,3′′′-{[pyrazine-2,3,5,6-tetrayltetrakis(methylene)]tetrakis(sulfanediyl)}tetrapropionic acid: crystal structures of two triclinic polymorphs and of two potassium–organic frameworks |
title_full_unstemmed | A new tetrakis-substituted pyrazine carboxylic acid, 3,3′,3′′,3′′′-{[pyrazine-2,3,5,6-tetrayltetrakis(methylene)]tetrakis(sulfanediyl)}tetrapropionic acid: crystal structures of two triclinic polymorphs and of two potassium–organic frameworks |
title_short | A new tetrakis-substituted pyrazine carboxylic acid, 3,3′,3′′,3′′′-{[pyrazine-2,3,5,6-tetrayltetrakis(methylene)]tetrakis(sulfanediyl)}tetrapropionic acid: crystal structures of two triclinic polymorphs and of two potassium–organic frameworks |
title_sort | new tetrakis-substituted pyrazine carboxylic acid, 3,3′,3′′,3′′′-{[pyrazine-2,3,5,6-tetrayltetrakis(methylene)]tetrakis(sulfanediyl)}tetrapropionic acid: crystal structures of two triclinic polymorphs and of two potassium–organic frameworks |
topic | Research Communications |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8100264/ https://www.ncbi.nlm.nih.gov/pubmed/34026250 http://dx.doi.org/10.1107/S2056989021003479 |
work_keys_str_mv | AT pacificojessica anewtetrakissubstitutedpyrazinecarboxylicacid3333pyrazine2356tetrayltetrakismethylenetetrakissulfanediyltetrapropionicacidcrystalstructuresoftwotriclinicpolymorphsandoftwopotassiumorganicframeworks AT stoecklievanshelen anewtetrakissubstitutedpyrazinecarboxylicacid3333pyrazine2356tetrayltetrakismethylenetetrakissulfanediyltetrapropionicacidcrystalstructuresoftwotriclinicpolymorphsandoftwopotassiumorganicframeworks AT pacificojessica newtetrakissubstitutedpyrazinecarboxylicacid3333pyrazine2356tetrayltetrakismethylenetetrakissulfanediyltetrapropionicacidcrystalstructuresoftwotriclinicpolymorphsandoftwopotassiumorganicframeworks AT stoecklievanshelen newtetrakissubstitutedpyrazinecarboxylicacid3333pyrazine2356tetrayltetrakismethylenetetrakissulfanediyltetrapropionicacidcrystalstructuresoftwotriclinicpolymorphsandoftwopotassiumorganicframeworks |